Modulation of GSK-3 as a Therapeutic Strategy on Tau Pathologies

Miguel Medina(Baptist Hospital of Miami), Francisco Wandosell(Consejo Superior de Investigaciones Científicas)

Frontiers in Molecular Neuroscience

January 1, 2011

10.3389/fnmol.2011.00024

Cited by 115

Related Papers

Parkin Localizes to the Lewy Bodies of Parkinson Disease and Dementia with Lewy Bodies

|American Journal Of Pathology|2002|331

Deconstructing GSK‐3: The Fine Regulation of Its Activity

|International Journal of Alzheimer s Disease|2011|160

Cancer Stem Cell-Like Phenotype and Survival Are Coordinately Regulated by Akt/FoxO/Bim Pathway

|Stem Cells|2014|84

Clearance of β‐amyloid mediated by autophagy is enhanced by <scp>MTORC1</scp> inhibition but not <scp>AMPK</scp> activation in <scp>APP</scp>/<scp>PSEN1</scp> astrocytes

|Glia|2023|15